logo
Share SHARE
FONT-SIZE Plus   Neg

Court Rules In Favor Of Boston Scientific In Johnson & Johnson Litigation

Medical device maker Boston Scientific Corp. (BSX: Quote) announced that the U.S. District Court for the District of New Jersey has found all the asserted patents in a suit brought by Healthcare giant Johnson & Johnson (JNJ: Quote) to be invalid and entered judgment in favor of Boston Scientific.

Under the 2008 patent infringement suit, Johnson & Johnson alleged that Boston Scientific's PROMUS Everolimus-Eluting Coronary Stent System infringed two patents, U.S. Patent Nos. 5,516,781 and 5,563,146. The patents relate to the use of a drug on a drug-eluting stent.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
UK-based oil giant BP Plc. and French peer Total SA Tuesday reported lower profit for the first quarter, as oil prices declined sharply from the previous year. However, results reflected stronger overall refining environment. Hartford Financial reported a decline in first-quarter profit, despite growth in premiums, due mainly to the absence of gains recorded last year. Apple Inc. said Monday after the markets closed that its second quarter profit rose 33% from last year, driven by strong sales of iPhone and Mac as well as all-time record performance of the App Store. The company's quarterly earnings per share also breezed past Wall Street expectations as did its quarterly sales.
comments powered by Disqus
RELATED NEWS
Trade BSX now with 
Follow RTT